Tweet

Dear Friends and Customers,
 
FDA’s Import Operations currently remain functional and operational.  Activities including FDA Prior Notice review, FDA entry processing, FDA sampling/examination of high risk shipments, FSVP inspections, filer assessments, and compliance activities are all ongoing.
 
While most import operations are not currently experiencing delays, the import community should expect delays in the receipt of hard copy notices. FDA will have a lessened capacity to generate and mail hard-copy Notices of FDA Action (release notices, sampling notices, etc.). FDA strongly encourages all members of the import community who deal in FDA-regulated articles to utilize the FDA Import Trade Auxiliary Communication System (ITACS) for current entry status and to receive FDA notices electronically.
 
FDA is continuously monitoring COVID-19 events and will provide updates as circumstances warrant. Additionally, COVID-19 information can be found on FDA’s website for Coronavirus Disease 2019 (COVID-19).
 
Feel free to contact us for any questions or comments.
Compliance.clx@rljones.com

Sincerely,
Department of Compliance